Recent reports in Emerging Markets Economy, MENA Report and Alternativa News reveal that India-based Glenmark Pharmaceuticals Ltd may be facing quite a number of problems, including quality control issues of several of its products, the deaths of clinical trial animals administered its drugs, and strife between companies in cooperation with the firm, to name a few. Serious quality control issues have recently arisen with a popular antibacterial medication widely marketed ...